Tsumura & Co. (FRA:TSUA)

Germany · Delayed Price · Currency is EUR

19.30

+0.10 (0.52%)

At close: Aug 26, 2026

-14.22% (1Y)

Market Cap	1.53B -3.7%
Revenue (ttm)	1.07B +10.4%
Net Income	162.66M +17.9%
EPS	2.18 +19.7%
Shares Out	n/a
PE Ratio	9.38
Forward PE	n/a
Dividend	0.85 (4.45%)
Ex-Dividend Date	Sep 29, 2026

Volume	n/a
Open	19.40
Previous Close	19.20
Day's Range	19.30 - 19.40
52-Week Range	18.00 - 23.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal/throat inflammation symptoms. It is also involved in manufacturing and sales of prescription drugs and over-the-counter Kampo medicines. Tsumura & Co. was foun... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1893

Employees 4,923

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol TSUA

Financial Performance

In fiscal year 2026, Tsumura & Co.'s revenue was 192.62 billion, an increase of 6.36% compared to the previous year's 181.09 billion. Earnings were 28.12 billion, a decrease of -13.29%.

Financial numbers in JPY Financial Statements